Showing 321 - 340 results of 11,927 for search '"Hepatocellular carcinoma"', query time: 0.19s Refine Results
  1. 321

    Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma by Anastasia Asimakopoulou, Mihael Vucur, Tom Luedde, Silvia Schneiders, Stavroula Kalampoka, Thomas S. Weiss, Ralf Weiskirchen

    Published 2019-03-01
    “…Hepatocellular carcinoma (HCC) is one of the most prevalent and deadly cancers worldwide. …”
    Get full text
    Article
  2. 322

    NF-Y Overexpression in Liver Hepatocellular Carcinoma (HCC) by Eugenia Bezzecchi, Mirko Ronzio, Roberto Mantovani, Diletta Dolfini

    Published 2020-12-01
    “…We report here on the overexpression of all subunits in the liver hepatocellular carcinoma (HCC) TCGA database, specifically the short NF-YAs and NF-YC2 (37 kDa) isoforms. …”
    Get full text
    Article
  3. 323

    Insights into the Role of Oxidative Stress in Hepatocellular Carcinoma Development by Yuanyuan Li, Yang Yu, Lei Yang, Rui Wang

    Published 2023-11-01
    “…Oxidative stress (OS) is linked to hepatocellular carcinoma (HCC) progression. HCC may develop as a result of genetic changes, including oxidative injury to both nuclear and mitochondrial DNA. …”
    Get full text
    Article
  4. 324
  5. 325
  6. 326
  7. 327
  8. 328
  9. 329
  10. 330
  11. 331
  12. 332
  13. 333

    VOCs from Exhaled Breath for the Diagnosis of Hepatocellular Carcinoma by Thanikan Sukaram, Terapap Apiparakoon, Thodsawit Tiyarattanachai, Darlene Ariyaskul, Kittipat Kulkraisri, Sanparith Marukatat, Rungsun Rerknimitr, Roongruedee Chaiteerakij

    Published 2023-01-01
    “…Background: Volatile organic compound (VOC) profiles as biomarkers for hepatocellular carcinoma (HCC) are understudied. We aimed to identify VOCs from the exhaled breath for HCC diagnosis and compare the performance of VOCs to alpha-fetoprotein (AFP). …”
    Get full text
    Article
  14. 334
  15. 335
  16. 336
  17. 337

    Autophagy and biotransformation affect sorafenib resistance in hepatocellular carcinoma by Ruiqi Zheng, Shuang Weng, Jianping Xu, Zhuo Li, Yaru Wang, Zulihumaer Aizimuaji, Sheng Ma, Linlin Zheng, Haiyang Li, Wantao Ying, Weiqi Rong, Ting Xiao

    Published 2023-01-01
    “…As sorafenib is a first-line drug for treating advanced hepatocellular carcinoma, sorafenib resistance has historically attracted attention. …”
    Get full text
    Article
  18. 338
  19. 339
  20. 340